Cargando…
Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
BACKGROUND: Coronavirus infectious disease 2019 (COVID-19) is primarily a respiratory disease. However, it may manifest with gastrointestinal symptoms that may overlap with Clostridioides difficile infection (CDI). COVID-19 appears to have higher mortality in those with comorbidities. We aimed to as...
Autores principales: | Sehgal, Kanika, Fadel, Hind J, Tande, Aaron J, Pardi, Darrell S, Khanna, Sahil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089469/ https://www.ncbi.nlm.nih.gov/pubmed/33953575 http://dx.doi.org/10.2147/IDR.S305349 |
Ejemplares similares
-
Immune response against Clostridioides difficile and translation to therapy
por: Sehgal, Kanika, et al.
Publicado: (2021) -
The interplay of Clostridioides difficile
infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021) -
Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface
por: Sehgal, Kanika, et al.
Publicado: (2021) -
The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021) -
Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection
por: Saha, Srishti, et al.
Publicado: (2021)